Cerus Corp
NASDAQ:CERS
$3.20
-$0.02
(-0.62%)
Quote as of 4:00 PM EST on 02/10/12
Extended Hours:
$3.25
$0.05
(1.56%)
Quote as of 4:31 PM EST on 02/10/12 (NASDAQ)
|
$3.20
-$0.02
(-0.62%)
|
|
| Today's Open | $3.20 |
|---|---|
| Previous Close | $3.22 |
| Daily Range | $3.12 - $3.25 |
| 52-Week Range | $1.92 - $3.67 |
| Market Cap | $153.92M |
| P/E Ratio | -13.42 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 491,597 |
| Average Daily Volume | 386,220 |
| Current FY EPS | -$0.31 |
CERS Information
| Description |
|---|
| The Company develops and commercializes novel, proprietary products and technologies within the fields of blood safety and immunotherapy that provides safer and more medical options to patients in areas of unmet medical need. |
| Sector |
| Healthcare |
| Industry |
| Healthcare Equipment and Supplies |
News & Commentary
Low-Priced Biotech Stocks With Insider Buying
Analyst Calls: AMTD, C, COF, DLTR, FL, GS, IBM, INTC, NYT, PGR, SCHW ...
Cerus Postpones Feb. 22 Earnings Release
Which of These Small Stocks Can Climb Even Higher?
Why Cerus Is My Stock of the Year
FOMC Minutes and How to Play the Non-Rebound Rebound
Jobless Claims Cut Through the Noise
15 Biotech Stocks With the Lowest Put/Call Ratios
UPDATE 1-Cerus in development deal for blood safety system
